Bruno Sangro

39PUBLICATIONS
179CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTransplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Jun 10, 2026
Trial design and end points in hepatocellular carcinoma: an EASL-AASLD-ILCA consensus statement.

|Mar 19, 2026
Immunogenicity of neoantigens from hepatocellular carcinoma patients treated with a combined radioimmunotherapy.

Belén Aparicio, Leyre Silva, Marta Ruiz

|Mar 09, 2026
First-in-human phase 1 study of RO7119929, an oral TLR7 agonist prodrug, in patients with advanced primary or metastatic liver cancers.

Changhoon Yoo, Carles Fabregat-Franco, Chia-Chi Lin

|Dec 16, 2025
Response evaluation to systemic therapy in HCC: Current challenges and future perspectives.

Mario Matute-González, Maxime Ronot, Victoria Chernyak

|Oct 21, 2025
Pan-microbial serological repertoire as a biomarker of immunotherapy response in hepatocellular carcinoma.

Shay Behrens, Whitney Leet Do, Limin Wang

|Sep 13, 2025
Immune-Checkpoint Inhibitors for Biliary Tract Cancer: Who Benefits and What Is Next?

Lucía Ceniceros, Manuel de La Torre, Ana Landa Magdalena

Pageof 7

Frequent Collaborators

6 joint publications

Josepmaria Argemí

6 joint publications

José Ignacio Bilbao

5 joint publications

Jorge Aramburu

4 joint publications

Juan Pablo Unfried